200 related articles for article (PubMed ID: 30322188)
1. A Structure- and Ligand-Based Virtual Screening of a Database of "Small" Marine Natural Products for the Identification of "Blue" Sigma-2 Receptor Ligands.
Floresta G; Amata E; Barbaraci C; Gentile D; Turnaturi R; Marrazzo A; Rescifina A
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30322188
[TBL] [Abstract][Full Text] [Related]
2. Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands.
Floresta G; Rescifina A; Marrazzo A; Dichiara M; Pistarà V; Pittalà V; Prezzavento O; Amata E
Eur J Med Chem; 2017 Oct; 139():884-891. PubMed ID: 28866257
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive 3D-QSAR Model Predicts Binding Affinity of Structurally Diverse Sigma 1 Receptor Ligands.
Peng Y; Dong H; Welsh WJ
J Chem Inf Model; 2019 Jan; 59(1):486-497. PubMed ID: 30497261
[TBL] [Abstract][Full Text] [Related]
4. Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands.
van Waarde A; Rybczynska AA; Ramakrishnan N; Ishiwata K; Elsinga PH; Dierckx RA
Curr Pharm Des; 2010; 16(31):3519-37. PubMed ID: 21050178
[TBL] [Abstract][Full Text] [Related]
5. Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
van Waarde A; Rybczynska AA; Ramakrishnan NK; Ishiwata K; Elsinga PH; Dierckx RA
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2703-14. PubMed ID: 25173780
[TBL] [Abstract][Full Text] [Related]
6. Sigma-2 ligands and PARP inhibitors synergistically trigger cell death in breast cancer cells.
McDonald ES; Mankoff J; Makvandi M; Chu W; Chu Y; Mach RH; Zeng C
Biochem Biophys Res Commun; 2017 May; 486(3):788-795. PubMed ID: 28347815
[TBL] [Abstract][Full Text] [Related]
7. Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis.
Rescifina A; Floresta G; Marrazzo A; Parenti C; Prezzavento O; Nastasi G; Dichiara M; Amata E
Eur J Pharm Sci; 2017 Aug; 106():94-101. PubMed ID: 28571781
[TBL] [Abstract][Full Text] [Related]
8. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
[TBL] [Abstract][Full Text] [Related]
9. The sigma-2 (σ-2) receptor: a review of recent patent applications: 2013-2018.
Blass BE; Rogers JP
Expert Opin Ther Pat; 2018 Sep; 28(9):655-663. PubMed ID: 30185082
[TBL] [Abstract][Full Text] [Related]
10. Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands.
Floresta G; Dichiara M; Gentile D; Prezzavento O; Marrazzo A; Rescifina A; Amata E
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678129
[TBL] [Abstract][Full Text] [Related]
11. Another brick in the wall. Validation of the σ1 receptor 3D model by computer-assisted design, synthesis, and activity of new σ1 ligands.
Laurini E; Marson D; Dal Col V; Fermeglia M; Mamolo MG; Zampieri D; Vio L; Pricl S
Mol Pharm; 2012 Nov; 9(11):3107-26. PubMed ID: 23020867
[TBL] [Abstract][Full Text] [Related]
12. Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo.
Mach RH; Wheeler KT
Cent Nerv Syst Agents Med Chem; 2009 Sep; 9(3):230-45. PubMed ID: 20021357
[TBL] [Abstract][Full Text] [Related]
13. Computational screening of natural and natural-like compounds to identify novel ligands for sigma-2 receptor.
Alamri MA; Afzal O; Alamri MA
SAR QSAR Environ Res; 2020 Nov; 31(11):837-856. PubMed ID: 33100033
[TBL] [Abstract][Full Text] [Related]
14. Design and Investigation of a [
Yang D; Comeau A; Bowen WD; Mach RH; Ross BD; Hong H; Van Dort ME
Mol Pharm; 2017 Mar; 14(3):770-780. PubMed ID: 28135101
[TBL] [Abstract][Full Text] [Related]
15. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.
Hayashi T; Su TP
CNS Drugs; 2004; 18(5):269-84. PubMed ID: 15089113
[TBL] [Abstract][Full Text] [Related]
16. 5D-QSAR for spirocyclic sigma1 receptor ligands by Quasar receptor surface modeling.
Oberdorf C; Schmidt TJ; Wünsch B
Eur J Med Chem; 2010 Jul; 45(7):3116-24. PubMed ID: 20427100
[TBL] [Abstract][Full Text] [Related]
17. Arylamides hybrids of two high-affinity σ2 receptor ligands as tools for the development of PET radiotracers.
Abate C; Ferorelli S; Contino M; Marottoli R; Colabufo NA; Perrone R; Berardi F
Eur J Med Chem; 2011 Sep; 46(9):4733-41. PubMed ID: 21684636
[TBL] [Abstract][Full Text] [Related]
18. Targeting nuclear receptors with marine natural products.
Yang C; Li Q; Li Y
Mar Drugs; 2014 Jan; 12(2):601-35. PubMed ID: 24473166
[TBL] [Abstract][Full Text] [Related]
19. Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy.
Huang YS; Lu HL; Zhang LJ; Wu Z
Med Res Rev; 2014 May; 34(3):532-66. PubMed ID: 23922215
[TBL] [Abstract][Full Text] [Related]
20. Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.
Laggner C; Schieferer C; Fiechtner B; Poles G; Hoffmann RD; Glossmann H; Langer T; Moebius FF
J Med Chem; 2005 Jul; 48(15):4754-64. PubMed ID: 16033255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
